Subha Bakthavatsalam
subha.bakthavatsalam@duke.edu
Subha is working on developing novel targeted prodrugs for prostate cancer based on prochelators. These prochelators get specifically activated to bind to metal ions in cancer tissue.
Subha
Subha Bakthavatsalam
subha.bakthavatsalam@duke.edu
Subha is working on developing novel targeted prodrugs for prostate cancer based on prochelators. These prochelators get specifically activated to bind to metal ions in cancer tissue.
|